A randomised, placebo-controlled, phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma (I-MAT Trial)

W. Xu,M. Poulsen,V. Atkinson,G. Fogarty,M. Veness, B. Smithers,D. Gyorki,V. Mar,J. Howle,A. Guminski, N. Williams,E. Paton

AUSTRALASIAN JOURNAL OF DERMATOLOGY（2021）

引用 0|浏览12

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要